Mitochondrial Complex I Inhibitors and Forced Oxidative Phosphorylation Synergize in Inducing Cancer Cell Death

Cancer cells generally rely mostly on glycolysis rather than oxidative phosphorylation (OXPHOS) for ATP production. In fact, they are particularly sensitive to glycolysis inhibition and glucose depletion. On the other hand mitochondrial dysfunctions, involved in the onset of the Warburg effect, are...

Full description

Saved in:
Bibliographic Details
Main Authors: Roberta Palorini, Tiziana Simonetto, Claudia Cirulli, Ferdinando Chiaradonna
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Cell Biology
Online Access:http://dx.doi.org/10.1155/2013/243876
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564256031113216
author Roberta Palorini
Tiziana Simonetto
Claudia Cirulli
Ferdinando Chiaradonna
author_facet Roberta Palorini
Tiziana Simonetto
Claudia Cirulli
Ferdinando Chiaradonna
author_sort Roberta Palorini
collection DOAJ
description Cancer cells generally rely mostly on glycolysis rather than oxidative phosphorylation (OXPHOS) for ATP production. In fact, they are particularly sensitive to glycolysis inhibition and glucose depletion. On the other hand mitochondrial dysfunctions, involved in the onset of the Warburg effect, are sometimes also associated with the resistance to apoptosis that characterizes cancer cells. Therefore, combined treatments targeting both glycolysis and mitochondria function, exploiting peculiar tumor features, might be lethal for cancer cells. In this study, we show that glucose deprivation and mitochondrial Complex I inhibitors synergize in inducing cancer cell death. In particular, our results reveal that low doses of Complex I inhibitors, ineffective on immortalized cells and in high glucose growth, become specifically cytotoxic on cancer cells deprived of glucose. Importantly, the cytotoxic effect of the inhibitors on cancer cells is strongly enhanced by forskolin, a PKA pathway activator, that we have previously shown to stimulate OXPHOS. Taken together, we demonstrate that induction in cancer cells of a switch from a glycolytic to a more respirative metabolism, obtained by glucose depletion or mitochondrial activity stimulation, strongly increases their sensitivity to low doses of mitochondrial Complex I inhibitors. Our findings might be a valuable approach to eradicate cancer cells.
format Article
id doaj-art-455cb510582e44a28c98b4451096271a
institution Kabale University
issn 1687-8876
1687-8884
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series International Journal of Cell Biology
spelling doaj-art-455cb510582e44a28c98b4451096271a2025-02-03T01:11:25ZengWileyInternational Journal of Cell Biology1687-88761687-88842013-01-01201310.1155/2013/243876243876Mitochondrial Complex I Inhibitors and Forced Oxidative Phosphorylation Synergize in Inducing Cancer Cell DeathRoberta Palorini0Tiziana Simonetto1Claudia Cirulli2Ferdinando Chiaradonna3Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milan, ItalyDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milan, ItalyDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milan, ItalyDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milan, ItalyCancer cells generally rely mostly on glycolysis rather than oxidative phosphorylation (OXPHOS) for ATP production. In fact, they are particularly sensitive to glycolysis inhibition and glucose depletion. On the other hand mitochondrial dysfunctions, involved in the onset of the Warburg effect, are sometimes also associated with the resistance to apoptosis that characterizes cancer cells. Therefore, combined treatments targeting both glycolysis and mitochondria function, exploiting peculiar tumor features, might be lethal for cancer cells. In this study, we show that glucose deprivation and mitochondrial Complex I inhibitors synergize in inducing cancer cell death. In particular, our results reveal that low doses of Complex I inhibitors, ineffective on immortalized cells and in high glucose growth, become specifically cytotoxic on cancer cells deprived of glucose. Importantly, the cytotoxic effect of the inhibitors on cancer cells is strongly enhanced by forskolin, a PKA pathway activator, that we have previously shown to stimulate OXPHOS. Taken together, we demonstrate that induction in cancer cells of a switch from a glycolytic to a more respirative metabolism, obtained by glucose depletion or mitochondrial activity stimulation, strongly increases their sensitivity to low doses of mitochondrial Complex I inhibitors. Our findings might be a valuable approach to eradicate cancer cells.http://dx.doi.org/10.1155/2013/243876
spellingShingle Roberta Palorini
Tiziana Simonetto
Claudia Cirulli
Ferdinando Chiaradonna
Mitochondrial Complex I Inhibitors and Forced Oxidative Phosphorylation Synergize in Inducing Cancer Cell Death
International Journal of Cell Biology
title Mitochondrial Complex I Inhibitors and Forced Oxidative Phosphorylation Synergize in Inducing Cancer Cell Death
title_full Mitochondrial Complex I Inhibitors and Forced Oxidative Phosphorylation Synergize in Inducing Cancer Cell Death
title_fullStr Mitochondrial Complex I Inhibitors and Forced Oxidative Phosphorylation Synergize in Inducing Cancer Cell Death
title_full_unstemmed Mitochondrial Complex I Inhibitors and Forced Oxidative Phosphorylation Synergize in Inducing Cancer Cell Death
title_short Mitochondrial Complex I Inhibitors and Forced Oxidative Phosphorylation Synergize in Inducing Cancer Cell Death
title_sort mitochondrial complex i inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death
url http://dx.doi.org/10.1155/2013/243876
work_keys_str_mv AT robertapalorini mitochondrialcomplexiinhibitorsandforcedoxidativephosphorylationsynergizeininducingcancercelldeath
AT tizianasimonetto mitochondrialcomplexiinhibitorsandforcedoxidativephosphorylationsynergizeininducingcancercelldeath
AT claudiacirulli mitochondrialcomplexiinhibitorsandforcedoxidativephosphorylationsynergizeininducingcancercelldeath
AT ferdinandochiaradonna mitochondrialcomplexiinhibitorsandforcedoxidativephosphorylationsynergizeininducingcancercelldeath